Regeneron Pharmaceuticals, Inc. <REGN.O>: Wells Fargo Raises Target Price to $750 From $700
REGN•Related News
CIBC amends final terms for Euro Stoxx 50-linked notes XS3412706346, sets initial value at EUR 6,202.43
CM•
Replimune more than doubles after FDA panel backs skin cancer drug
REPL•
GATX declares quarterly dividend of $0.66 a share
GATX•
Nasdaq trade halt continues <OST.O> reason not available at 10:49 AM
OST•
Private sector wage gains lift US labor costs in second quarter
SPY•